Autonomous motivation | Adherence | ||||||||
---|---|---|---|---|---|---|---|---|---|
Fixed effects | β | p-value | η2p | β | p-value | η2p | |||
Between-subject predictors | |||||||||
Age | .13 | <.001*** | .02 | .13 | <.001*** | .02 | |||
Gender[female] | .07 | <.001*** | .01 | .13 | <.001*** | .02 | |||
Comorbity | .02 | <.001*** | .00 | −.02 | <.001*** | .00 | |||
Education level | .03 | <.001*** | .00 | .03 | <.001*** | .00 | |||
Vaccination status[unvaccinated] | −.25 | <.001*** | .03 | −.11 | <.001*** | .01 | |||
Aspect[severity] | −.04 | <.001*** | .04 | −.03 | <.001*** | .00 | |||
Risk perception | .37 | <.001*** | .15 | .25 | <.001*** | .09 | |||
Aspect[severity] : Risk perception | .11 | <.001*** | .06 | .09 | <.001*** | .05 | |||
Between-days predictors | |||||||||
Phases[Alpha] | −.14 | <.001*** | .04 | −.15 | <.001*** | .03 | |||
Phases[Delta] | −.30 | <.001*** | −.30 | <.001*** | |||||
Phases[Omicron] | −.32 | <.001*** | −.27 | <.001*** | |||||
Cross-level interactions | |||||||||
Phases[Alpha] : Aspect[severity] | .01 | <.001*** | .01 | .00 | .21 | .01 | |||
Phases[Delta] : Aspect[severity] | .10 | <.001*** | .08 | <.001*** | |||||
Phases[Omicron] : Aspect[severity] | .11 | <.001*** | .10 | <.001*** | |||||
Phases[Alpha] : Risk perception | .02 | <.001*** | .02 | .05 | <.001*** | .01 | |||
Phases[Delta]: Risk perception | −.06 | <.001*** | −.02 | <.001*** | |||||
Phases[Omicron]: Risk perception | −.06 | <.001*** | −.03 | <.001*** | |||||
Phases[Alpha] : Aspect[severity]: Risk perception | −.01 | <.001*** | .03 | .00 | .11 | .02 | |||
Phases[Delta] : Aspect[severity]: Risk perception | .04 | <.001*** | .04 | <.001*** | |||||
Phases[Omicron] : Aspect[severity]: Risk perception | .04 | <.001*** | .04 | <.001*** | |||||
Random effects: | |||||||||
Number of days | 0.14 | 0.17 | |||||||
Residual | 0.83 | 0.87 | |||||||
Max VIF | 3.56 | 3.76 | |||||||
R2(marginal/conditional) | .35/.41 | .29/.35 |